Bringing A Hub-and-Spoke Business Model to Regenerative Medicine
Bioverge
00:00
A VAIL: De-risking Drug Discovery
This chapter discusses the concept of clinical trials in a dish for rapid drug discovery using A VAIL. They explore how this approach can de-risk the process, improve cell therapy, and discuss potential partnerships.
Transcript
Play full episode
